19587235 |
Tumor suppressor function of laminin-binding alpha-dystroglycan requires a distinct beta3-N-acetylglucosaminyltransferase
Fukuda, M,
Bao, X,
Nakayama, J,
Gullberg, D,
Kobayashi, M,
Angata, K,
Fukuda, MN,
Hatakeyama, S
|
Proc. Natl. Acad. Sci. U.S.A. |
2009 |
23359570 |
Missense mutations in β-1,3-N-acetylglucosaminyltransferase 1 (B3GNT1) cause Walker-Warburg syndrome
Babul-Hirji, R,
Kamsteeg, EJ,
van Bokhoven, H,
Blaser, S,
van Beusekom, E,
Chitayat, D,
van Reeuwijk, J,
Powell, G,
Lefeber, DJ,
van den Elzen, C,
Halliday, W,
Riemersma, M,
Stemple, DL,
Wright, GJ,
Lin, YY,
Buysse, K,
Roscioli, T
|
Hum Mol Genet |
2013 |
25279697 |
B4GAT1 is the priming enzyme for the LARGE-dependent functional glycosylation of α-dystroglycan
Ramiah, A,
Moremen, KW,
Chinoy, ZS,
Boons, GJ,
Wells, L,
Praissman, JL,
Live, DH,
Wang, S
|
Elife |
2014 |
25279699 |
The glucuronyltransferase B4GAT1 is required for initiation of LARGE-mediated α-dystroglycan functional glycosylation
Inamori, K,
Willer, T,
Wright, KM,
Beltrán Valero de Bernabé, D,
Morgensen, G,
Yu, L,
Hara, Y,
Harvey, C,
Campbell, KP,
Venzke, D
|
Elife |
2014 |